According to CNBC, the Food and Drug Administration has released a report yesterday that they endorsed Johnson & Johnson’s single-shot COVID vaccine.

FDA’s Vaccines and Related Biological Products Advisory Committee was briefed on the vaccine’s availability and will vote on the request for emergency use by the end of the week.

Just like the vaccinations from Moderna and Pfizer, the committee is expected to approve the request within a day’s time, noting that the trials and safety data were “consistent with the recommendations set forth in FDA’s guidance Emergency Use Authorization for Vaccines to Prevent COVID-19.”

The side effects are similar to Moderna and Pfizer, which include headache and fatigue, muscle aches, nausea, and fever.

The CDC has reported that 44 million out of 331 million Americans have received their first does of the c=vaccine while up to 19 million have received their second dose.

The post FDA Endorses Johnson And Johnson’s Single-Shot Vaccine appeared first on The Source.